Multisystem Outcomes of GLP-1 Receptor Agonists Versus Active Comparators in Type 2 Diabetes: A Multicenter Target Trial Emulation
Journal of diabetes science and technology · 2026 Oct 28 · Vashisht R, Dhruva SS, Patel A et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 27 20:00 ETSource: Journal of diabetes science and technology
From the source
Read at pubmed.ncbi.nlm.nih.govMultisystem Outcomes of GLP-1 Receptor Agonists Versus Active Comparators in Type 2 Diabetes: A Multicenter Target Trial Emulation
Journal of diabetes science and technology · 2026 Oct 28 · Vashisht R, Dhruva SS, Patel A et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42949133/
